Search results
Enrolling in Medicare | UCNet
UC Newsroom· 6 days agoIf you’re like most people, when you turn 65 you will become eligible to enroll in Medicare, the federal program to provide older adults and those with disabilities or permanent kidney failure ...
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip By Investing.com
Investing.com· 1 day agoAstellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...
Navigating Vaccine Coverage for Seniors With Medicare Changes | ThinkAdvisor
ThinkAdvisor· 5 days agoThe COVID vaccine is just one of many that clients might want.
JD Supra: Cozen Currents: Casting Trump II: The Sequel
JD Supra· 4 days agoA second Trump administration would likely include both familiar faces from his first term and newcomers, but a lack of institutional guardrails means that former President Trump’s personnel ...
New Favorable OIG Advisory Opinion Allows Patient Assistant Programs Funded by Drug Manufacturers
The National Law Review· 5 days agoThe Office of Inspector General (OIG) recently issued a new favorable advisory opinion regarding...
How is President Biden closing the gap on health disparities for communities of color?
Erie Times News via Yahoo News· 5 days agoThat kind of savings can be life-changing for seniors. Next year, even more people will enjoy further cost reductions. Medicare enrollees will benefit from a flat $2,000 out-of-pocket cap on ...
Mirae Asset Global Investments Co. Ltd. Has $630,000 Stake in eHealth, Inc. (NASDAQ:EHTH)
ETF DAILY NEWS· 5 days agoMirae Asset Global Investments Co. Ltd. lifted its stake in shares of eHealth, Inc. (NASDAQ:EHTH – Free Report) by 101.8% in the 4th quarter, according to the company in its most recent filing ...
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip
Investing.com· 2 days agoAstellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...
Wave of Amicus Briefs Back Drug Price Plan at Trial Court Stage
Bloomberg Law· 5 days agoThe Biden administration’s efforts to fend off legal challenges from the pharmaceutical industry battling Medicare drug price negotiations has drawn reinforcements from officials and academics defending the program.
Unveiling Cigna (CI) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks· 2 days agoFree Report) is predicted by Wall Street analysts to post quarterly earnings of $6.17 per share, reflecting an increase of 14.1% compared to the same period last year. Analysts expect 'Medical Care Ratio - Cigna Healthcare' to come in at 81.9%.